Users Stopping Slimming Injections Put On Weight Four Times Faster Than Those on Conventional Diets

A recent study indicates that patients who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain lost weight much more quickly than those who stop conventional diet and exercise regimens.

Published data in a prominent medical journal shows that while obese individuals frequently drop about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing these drugs need to be aware of the danger of rapid rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.

Such speed of recovery means a reversion to original weight within about 18 months.

Weighing Therapies

The study, which reviewed dozens of trials involving thousands of participants, compared the effects of these new drugs with conventional dieting.

Scientists note that people who lose weight through diet and exercise typically experience a more gradual creep back—approximately 0.1 kg a month—after stopping.

Understanding the Fast Rebound

Nutrition scientists suggest the mechanism of the drugs explains the accelerated rebound.

These medications imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of the hormone levels far above than normal might result in the system to produce less of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making binge eating much more probable."

An Ongoing Issue?

Medical guidelines advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.

Many experts say that, due to the likelihood of relapse, the treatment should be considered life-long.

This opinion is echoed by drug manufacturers, who say that the findings "highlight the persistent nature of obesity," akin to managing diseases like high blood pressure.

Patient Testimonies

Users who have come off the jabs explain a intense resurgence of hunger.

"It was like a switch activating and you become ravenous," described one woman.

This difficulty is exacerbated if patients have not established permanent dietary or behavioural modifications during treatment.

Widespread Adoption

Survey data suggest that millions of people in the UK have tried these injections in the last 12 months, with demand continuing to grow.

• Adoption is greater among women than males.
• The 40s and 50s age group shows the greatest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians stress that while these medications are effective tools for shedding pounds, they are not a permanent cure and lasting health benefits hinges on integrated behavioural changes.